{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","metadata_created":"2019-07-08T19:52:15.292785","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-07-08T19:52:15.292797","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-07-08","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["vaccination antigrippale","grippe pandémique","méningococcie invasive à Neisseria meningitidis","antigrippal"],"en":["NACI Seasonal Influenza Vaccine","influenza","invasive meningococcal disease","pandemic influenza"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Numéro 45-6, le 6 juin 2019 : La grippe : mise à jour","en":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"830d110d-b50a-47dd-a3fa-40a425afa40c","related_relationship":"","name_translated":{"fr":"RMTC : Numéro 45-6, le 6 juin 2019 : La grippe : mise à jour","en":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update","language":["en"],"created":"2019-07-08T19:52:16.772777","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019.html","last_modified":null,"position":0,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"418bcfd4-00ab-4745-8337-d8721f464380","related_relationship":"","name_translated":{"fr":"RMTC : Numéro 45-6, le 6 juin 2019 : La grippe : mise à jour","en":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update","language":["fr"],"created":"2019-07-08T19:52:16.772786","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019.html","last_modified":null,"position":1,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4add9224-ef20-4d98-8ccd-9218df73f74f","related_relationship":"","name_translated":{"fr":"RMTC : Numéro 45-6, le 6 juin 2019 : La grippe : mise à jour","en":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update","language":["en"],"created":"2019-07-08T19:52:16.772789","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06-eng.pdf","last_modified":null,"position":2,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"59b14a8c-1646-43f0-b02f-aeccf29fdeb0","related_relationship":"","name_translated":{"fr":"RMTC : Numéro 45-6, le 6 juin 2019 : La grippe : mise à jour","en":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update","language":["fr"],"created":"2019-07-08T19:52:16.772792","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06f-fra.pdf","last_modified":null,"position":3,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"07852e91-3a43-47a1-b593-7a18a6ef4d07","related_relationship":"","name_translated":{"fr":"Sommaire du CCNI sur la grippe 2019–2020","en":"NACI Summary Influenza 2019–2020"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Summary Influenza 2019–2020","language":["en"],"created":"2019-07-08T19:52:16.772795","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-1-naci-influenza-vaccine-statement-2019-2020.html","last_modified":null,"position":4,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c392ff1d-3b3c-47ef-9dca-e64fb87f3898","related_relationship":"","name_translated":{"fr":"Sommaire du CCNI sur la grippe 2019–2020","en":"NACI Summary Influenza 2019–2020"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Summary Influenza 2019–2020","language":["fr"],"created":"2019-07-08T19:52:16.772797","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-1-declaration-ccni-vaccination-antigrippale-2019-2020.html","last_modified":null,"position":5,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ef5ef0ec-140c-414b-a97b-ecac489e9499","related_relationship":"","name_translated":{"fr":"Sommaire du CCNI sur la grippe 2019–2020","en":"NACI Summary Influenza 2019–2020"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Summary Influenza 2019–2020","language":["en"],"created":"2019-07-08T19:52:16.772800","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a01-eng.pdf","last_modified":null,"position":6,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2d83e7a5-3ddf-49a7-b7fd-f3ec8b552312","related_relationship":"","name_translated":{"fr":"Sommaire du CCNI sur la grippe 2019–2020","en":"NACI Summary Influenza 2019–2020"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Summary Influenza 2019–2020","language":["fr"],"created":"2019-07-08T19:52:16.772802","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a01f-fra.pdf","last_modified":null,"position":7,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ee7b1903-9084-41a3-b8c0-7d50c51a460d","related_relationship":"","name_translated":{"fr":"Quand utiliser les études sur l'efficacité réelle","en":"When to use vaccine effectiveness studies"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"When to use vaccine effectiveness studies","language":["en"],"created":"2019-07-08T19:52:16.772805","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-2-influenza-vaccine-effectiveness-studies-vaccination-decision.html","last_modified":null,"position":8,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eed132c9-fbf3-44d7-b0f6-b2261a2315b3","related_relationship":"","name_translated":{"fr":"Quand utiliser les études sur l'efficacité réelle","en":"When to use vaccine effectiveness studies"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"When to use vaccine effectiveness studies","language":["fr"],"created":"2019-07-08T19:52:16.772807","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-2-etudes-efficacite-reelle-vaccin-antigrippal-decider-vacciner.html","last_modified":null,"position":9,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"55a3b969-4def-45bf-8dd2-6ae2eeed6a6f","related_relationship":"","name_translated":{"fr":"Quand utiliser les études sur l'efficacité réelle","en":"When to use vaccine effectiveness studies"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"When to use vaccine effectiveness studies","language":["en"],"created":"2019-07-08T19:52:16.772810","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a02-eng.pdf","last_modified":null,"position":10,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d008fd96-d1f4-4ef2-a4ec-7d8ff004c599","related_relationship":"","name_translated":{"fr":"Quand utiliser les études sur l'efficacité réelle","en":"When to use vaccine effectiveness studies"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"When to use vaccine effectiveness studies","language":["fr"],"created":"2019-07-08T19:52:16.772812","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a02f-fra.pdf","last_modified":null,"position":11,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ab1bcf3e-d3f1-47b3-acc8-7d2e3acf6f1e","related_relationship":"","name_translated":{"fr":"PCGP : stratégies relatives aux mesures de santé publique 2019","en":"CPIP: Public health strategy 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPIP: Public health strategy 2019","language":["en"],"created":"2019-07-08T19:52:16.772815","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-3-canadian-pandemic-influenza-preparedness-public-health-strategy.html","last_modified":null,"position":12,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3739f539-fc6c-4f2c-9a35-4d350df25f14","related_relationship":"","name_translated":{"fr":"PCGP : stratégies relatives aux mesures de santé publique 2019","en":"CPIP: Public health strategy 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPIP: Public health strategy 2019","language":["fr"],"created":"2019-07-08T19:52:16.772817","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-3-preparation-grippe-pandemique-strategie-mesures-sante-publique.html","last_modified":null,"position":13,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a2e11b22-38d4-4a3c-98c4-3e13797de061","related_relationship":"","name_translated":{"fr":"PCGP : stratégies relatives aux mesures de santé publique 2019","en":"CPIP: Public health strategy 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPIP: Public health strategy 2019","language":["en"],"created":"2019-07-08T19:52:16.772820","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a03-eng.pdf","last_modified":null,"position":14,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a1e19f04-eb50-46b6-82ce-9dc922f6d17b","related_relationship":"","name_translated":{"fr":"PCGP : stratégies relatives aux mesures de santé publique 2019","en":"CPIP: Public health strategy 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CPIP: Public health strategy 2019","language":["fr"],"created":"2019-07-08T19:52:16.772822","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a03f-fra.pdf","last_modified":null,"position":15,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"19324976-ec84-4d7c-822a-a5db673a6cf4","related_relationship":"","name_translated":{"fr":"Augmentation de Neisseria meningitidis du sérogroupe W, 2019","en":"Increase in Serogroup W Neisseria meningitidis 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Increase in Serogroup W Neisseria meningitidis 2019","language":["en"],"created":"2019-07-08T19:52:16.772825","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-4-increase-serogroup-w-neisseria-meningitidis-invasive-meningococal.html","last_modified":null,"position":16,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ae005319-0c4c-4aa0-bc8e-971c64593f3e","related_relationship":"","name_translated":{"fr":"Augmentation de Neisseria meningitidis du sérogroupe W, 2019","en":"Increase in Serogroup W Neisseria meningitidis 2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Increase in Serogroup W Neisseria meningitidis 2019","language":["fr"],"created":"2019-07-08T19:52:16.772827","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-4-hausse-meningococcie-invasive-serogroupe-w-neisseria-meningitidis.html","last_modified":null,"position":17,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d4b8b48e-8772-43fe-a992-8a7262650848","related_relationship":"","name_translated":{"fr":"Augmentation de Neisseria meningitidis du sérogroupe W, 2019","en":"Increase in Serogroup W Neisseria meningitidis 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Increase in Serogroup W Neisseria meningitidis 2019","language":["en"],"created":"2019-07-08T19:52:16.772830","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a04-eng.pdf","last_modified":null,"position":18,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7da765f1-472d-4570-8d8b-0bd9cb64cf34","related_relationship":"","name_translated":{"fr":"Augmentation de Neisseria meningitidis du sérogroupe W, 2019","en":"Increase in Serogroup W Neisseria meningitidis 2019"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Increase in Serogroup W Neisseria meningitidis 2019","language":["fr"],"created":"2019-07-08T19:52:16.772832","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a04f-fra.pdf","last_modified":null,"position":19,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7fd586be-2bce-44c2-bc0d-65259751fb89","related_relationship":"","name_translated":{"fr":"Faible efficacité réelle du vaccin antigrippal 2018-2019 contre A(H3N2)","en":"2018–2019 influenza vaccine low effectiveness against A(H3N2)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2018–2019 influenza vaccine low effectiveness against A(H3N2)","language":["en"],"created":"2019-07-08T19:52:16.772835","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/article-5-id-news.html","last_modified":null,"position":20,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4494b0f8-5de3-43e3-ab24-26ad2effa89a","related_relationship":"","name_translated":{"fr":"Faible efficacité réelle du vaccin antigrippal 2018-2019 contre A(H3N2)","en":"2018–2019 influenza vaccine low effectiveness against A(H3N2)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2018–2019 influenza vaccine low effectiveness against A(H3N2)","language":["fr"],"created":"2019-07-08T19:52:16.772837","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-6-6-juin-2019/article-5-actualites-sur-les-mi.html","last_modified":null,"position":21,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c219a630-6fdd-44a9-b882-1dda117044eb","related_relationship":"","name_translated":{"fr":"Faible efficacité réelle du vaccin antigrippal 2018-2019 contre A(H3N2)","en":"2018–2019 influenza vaccine low effectiveness against A(H3N2)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2018–2019 influenza vaccine low effectiveness against A(H3N2)","language":["en"],"created":"2019-07-08T19:52:16.772840","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a05-eng.pdf","last_modified":null,"position":22,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e310ad99-9ae6-4596-8065-83e3b2ea0977","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8f50e4a8-28e9-430d-8b33-e4102935d18d","related_relationship":"","name_translated":{"fr":"Faible efficacité réelle du vaccin antigrippal 2018-2019 contre A(H3N2)","en":"2018–2019 influenza vaccine low effectiveness against A(H3N2)"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2018–2019 influenza vaccine low effectiveness against A(H3N2)","language":["fr"],"created":"2019-07-08T19:52:16.772842","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-6-june-6-2019/ccdrv45i06a05f-fra.pdf","last_modified":null,"position":23,"revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10","resource_type":"website"}],"place_of_publication":[],"num_resources":24,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2019-06-10 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"e310ad99-9ae6-4596-8065-83e3b2ea0977","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 45-6 June 6, 2019: Influenza: An update","revision_id":"a599c72b-0d4b-42cb-b561-69107c20ef10"}